Newsletter of MEDICA | View in browser | Deutsch | Print
Header of MEDICA Newsletter

Technologies for precise infection diagnostics

Dear Sir or Madam,

How are AI, FFP2 masks and antibody tests reshaping infection diagnostics? Discover modern technologies enabling precise diagnoses - and why these innovations are crucial for global health.

Enjoy reading!

Tim Plato
Editorial team MEDICA-tradefair.com

Table of Contents
Article: Optimizing infection diagnostics
Newsletter Service

Optimizing infection diagnostics with AI, masks and antibody tests

Article - LAB & DIAGNOSTICS
Image: Person in protective clothing conducting research in a laboratory and holding a tablet in their hands
What role will AI, FFP2 masks and antibody tests play in the future of infection diagnostics? Find out how current technologies are opening up new avenues for precise diagnoses!
Click here for the article
Modern approaches for more precise infection diagnostics
Image: Banner with the text: Discover the world of LAB & DIAGNOSTICS here; Copyright: Messe Düsseldorf
To top

Early detection: machine learning in cardiovascular diagnostics

News

DIGITAL HEALTH
Researchers at Graz University of Technology have developed a method for the early detection of cardiovascular diseases before symptoms occur. Using a machine learning model that analyzes electric fields, potential diseases can be precisely identified. This technology could improve diagnostics and reduce invasive interventions.
read more
To top

Two-photon microscope enables faster, less harmful brain imaging

News

MED TECH & DEVICES
Researchers at the University of California, Davis, have developed a new two-photon fluorescence microscope capable of capturing high-speed images of neural activity with cellular resolution.
read more
To top

Controlling organoid development with the help of DNA microspheres

News

LAB & DIAGNOSTICS
A research team from Heidelberg University and the Max Planck Institute for Medical Research has developed a new method of molecular engineering. This makes it possible to precisely control organoids and improve their complexity. With the help of DNA microspheres, growth factors can be released in a targeted manner to recreate tissue structures more realistically.
read more
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to medica-redaktion@messe-duesseldorf.de.
To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 211 4560-01
Fax: +49 211 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Wolfram N. Diener (Chairman), Marius Berlemann, Bernhard J. Stempfle

Chairman of Supervisory Board: Mayor Dr. Stephan Keller

Messe Düsseldorf GmbH processes personal data relating to you. You can find more information - also on your rights - in the privacy policy of Messe Düsseldorf GmbH available at www.messe-duesseldorf.de/privacy. In principle, i.e. subject to legal restrictions, you may at any time object to the processing of your personal data either on the aforementioned website, via e-mail to privacy@messe-duesseldorf.de or via postal mail to Messe Düsseldorf GmbH, G2-RV, PF 101006, 40001 Düsseldorf, Germany.

Facebook LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.